Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1878064

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1878064

Medical Polyoxymethylene (POM) Market - Forecasts from 2025 to 2030

PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The medical polyoxymethylene (POM) market is expected to grow at a CAGR of 5.01%, from US$ 84.981 million in 2025 to US$108.511 million in 2030.

Medical Polyoxymethylene (POM), commonly known as acetal, is a high-performance engineering thermoplastic valued in the healthcare industry for its exceptional properties. Medical-grade POM is specifically formulated to withstand repeated cleaning with various sanitizing solutions and can be sterilized using standard methods such as hot steam. Its unique combination of high stiffness, excellent dimensional stability, low friction coefficient, and strong chemical resistance makes it an ideal material for a wide range of medical applications. Furthermore, its inherent biocompatibility ensures it does not cause harmful reactions with human tissue, which is a prerequisite for many medical devices. The material is commercially available in two primary forms: homopolymer POM, which offers high crystallinity and stiffness, and copolymer POM, which provides benefits such as enhanced oxidation and creep resistance.

A primary driver for the medical POM market is the rising global demand for medical devices and equipment. POM is extensively utilized in manufacturing devices that require frequent sterilization and reliable performance, including surgical tools, orthopedic implants, and drug delivery systems. The biocompatibility and chemical invariance of POM make it a preferred material as medical technology advances toward more complex devices. The growth of the medical device industry, coupled with stringent regulatory standards that favor materials with a proven track record of safety and reliability, continues to propel the consumption of medical POM. The versatility of this polymer ensures its application across surgical instruments, implantable devices, and diagnostic tools, aligning with the increasing consumption of healthcare facilities worldwide. Additionally, the growing demand for sustainable materials in healthcare is fostering the use of POM, as it is a recyclable material, leading manufacturers to incorporate recycled content to reduce environmental footprint.

The application segmentation of the medical POM market reveals several key growth areas. Dialysis machines represent a significant application segment. These machines, essential for patients with kidney failure, utilize POM for components that require chemical resistance and durability. The increasing global prevalence of conditions like diabetes and hypertension, which are leading causes of kidney failure, is expected to sustain the demand for dialysis machines and, consequently, for medical POM. Inhalers constitute another expanding application. The rising incidence of respiratory ailments such as asthma, driven in part by ambient and household air pollution, is increasing the demand for metered-dose inhalers, for which POM is a suitable material. Furthermore, the demand for insulin pens is a major contributor to market expansion. The growing global diabetic population is driving the need for effective diabetes care options. Insulin pens, which rely on POM for their durability, dimensional stability, and ability to protect the insulin cartridge from leakage or damage under varying conditions, are seeing increased adoption, thereby fueling the consumption of medical POM in their manufacturing.

From a geographical perspective, the Asia Pacific region, and particularly China, is witnessing substantial market growth. This expansion is fueled by rapid industrialization, urbanization, and the consequent development of healthcare infrastructure in emerging economies. Government initiatives aimed at boosting domestic manufacturing, such as industrial promotion schemes, are creating favorable conditions for the medical industry and the materials that supply it. In China specifically, the high prevalence of diabetes has led to widespread adoption of insulin pens, making it a key driver for the POM market. The country's rapidly expanding medical device industry, supported by government efforts to enhance healthcare facilities, directly increases the production and consumption of POM. A growing customer awareness and regulatory push for sustainable products are also shifting preferences towards materials like POM over less environmentally friendly alternatives.

The North American market is also expected to grow significantly, driven by the presence of established international medical and pharmaceutical companies. High healthcare expenditure and a well-developed medical device manufacturing base contribute to steady demand. The growing need for devices such as dialysis machines, propelled by rising rates of kidney failure, is a specific factor increasing the consumption of medical POM in the region.

The market is supported by product offerings from leading global chemical companies. These corporations provide specialized medical-grade POM brands that comply with stringent regulatory requirements. Their product portfolios include various grades designed for high-performance medical applications, and they often provide extensive technical support to medical device manufacturers, assisting with material selection, design optimization, and product development to ensure optimal performance and compliance.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY TYPE
  • Copolymer POM
  • Homopolymer POM
  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY APPLICATION
  • Dialysis Machine
  • Inhalers
  • Medical Trays
  • Surgical Instruments
  • Insulin Pen
  • Pharmaceutical Closures
  • Others
  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY END-USER
  • Hospital & Clincs
  • Surgical Centers
  • Others
  • MEDICAL POLYOXYMETHYLENE (POM) MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others
Product Code: KSI061615231

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Copolymer POM
  • 5.3. Homopolymer POM

6. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Dialysis Machine
  • 6.3. Inhalers
  • 6.4. Medical Trays
  • 6.5. Surgical Instruments
  • 6.6. Insulin Pen
  • 6.7. Pharmaceutical Closures
  • 6.8. Others

7. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospital & Clincs
  • 7.3. Surgical Centers
  • 7.4. Others

8. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Celanese Corporation
  • 10.2. BASF SE
  • 10.3. Ensinger Group
  • 10.4. Kolon Group
  • 10.5. Barlog Plastics GmbH
  • 10.6. SABIC
  • 10.7. Asahi Kasei Corporation
  • 10.8. Mitsubishi Chemical Corporation
  • 10.9. Delrin USA, LLC
  • 10.10. Polyplastics Co., Ltd

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!